MedPath

Prospective randomized double blind trial on the use of Scopoderm patch for control of post-operative nausea and vomitting in patients undergoing gynecologic laparoscopic procedures.

Conditions
Post-operative nausea and vomiting in patients undergoing gynecologic laparoscopic procedures.
Registration Number
EUCTR2005-005928-13-IS
Lead Sponsor
andspitali-University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Female
Target Recruitment
48
Inclusion Criteria

Patients scheduled to undergo gynecologic laparoscopic surgery at Landspitali University Hospital will be offered to participate. In order to detect a 25% difference in nausea between tha two groups we project that we will need to enroll 24 patients in each group for a total of 48 patients. This is assuming an alpha of 0.05 and a beta of 0.20.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Nursing and pregnant women, allergy to substances in the patch, narrow angle glaucoma.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath